Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Candace S. Johnson:

Search results

Items: 1 to 20 of 103

1.

Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness.

Ramakrishnan S, Steck SE, Arab L, Zhang H, Bensen JT, Fontham ETH, Johnson CS, Mohler JL, Smith GJ, Su LJ, Woloszynska A.

Prostate. 2019 Jul;79(10):1117-1124. doi: 10.1002/pros.23824. Epub 2019 May 11.

2.

Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.

Bunch BL, Ma Y, Attwood K, Amable L, Luo W, Morrison C, Guru KA, Woloszynska-Read A, Hershberger PA, Trump DL, Johnson CS.

Cancer Med. 2019 May;8(5):2449-2461. doi: 10.1002/cam4.2119. Epub 2019 Apr 10.

3.

Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy.

Wei L, Hussein AA, Ma Y, Azabdaftari G, Ahmed Y, Wong LP, Hu Q, Luo W, Cranwell VN, Bunch BL, Kozlowski JD, Singh PK, Glenn ST, Smith G, Johnson CS, Liu S, Guru KA.

J Urol. 2019 Jun;201(6):1105-1114. doi: 10.1097/JU.0000000000000142.

PMID:
30730413
4.

Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).

Steck SE, Omofuma OO, Su LJ, Maise AA, Woloszynska-Read A, Johnson CS, Zhang H, Bensen JT, Fontham ETH, Mohler JL, Arab L.

Am J Clin Nutr. 2018 May 1;107(5):799-807. doi: 10.1093/ajcn/nqy037.

PMID:
29722851
5.

1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.

Ma Y, Luo W, Bunch BL, Pratt RN, Trump DL, Johnson CS.

Oncotarget. 2017 Jul 27;8(36):60080-60093. doi: 10.18632/oncotarget.19629. eCollection 2017 Sep 1.

6.

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.

Wei L, Chintala S, Ciamporcero E, Ramakrishnan S, Elbanna M, Wang J, Hu Q, Glenn ST, Murakami M, Liu L, Gomez EC, Sun Y, Conroy J, Miles KM, Malathi K, Ramaiah S, Anbarasu A, Woloszynska-Read A, Johnson CS, Conroy J, Liu S, Morrison CD, Pili R.

Oncotarget. 2016 Nov 22;7(47):76374-76389. doi: 10.18632/oncotarget.13062.

7.

Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.

Wei L, Papanicolau-Sengos A, Liu S, Wang J, Conroy JM, Glenn ST, Brese E, Hu Q, Miles KM, Burgher B, Qin M, Head K, Omilian AR, Bshara W, Krolewski J, Trump DL, Johnson CS, Morrison CD.

BMC Med Genomics. 2016 Oct 19;9(1):64.

8.

Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib.

Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, Murakami M, Liu L, Hu Q, Conroy J, Miles KM, Nowak DE, Liu B, Qin M, Bshara W, Omilian AR, Head K, Bianchi M, Burgher B, Darlak C, Kane J, Merzianu M, Cheney R, Fabiano A, Salerno K, Talati C, Khushalani NI, Trump DL, Johnson CS, Morrison CD.

Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000380. doi: 10.1101/mcs.a000380.

9.

Vitamin D Signaling Modulators in Cancer Therapy.

Luo W, Johnson CS, Trump DL.

Vitam Horm. 2016;100:433-72. doi: 10.1016/bs.vh.2015.11.004. Epub 2016 Jan 13.

PMID:
26827962
10.

Mechanistic Insights of Vitamin D Anticancer Effects.

Ma Y, Johnson CS, Trump DL.

Vitam Horm. 2016;100:395-431. doi: 10.1016/bs.vh.2015.11.003. Epub 2016 Jan 13. Review.

PMID:
26827961
11.

Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.

Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, Hong CC, Zhu Q, Sucheston-Campbell L, Cheng TY, Bensen JT, Johnson CS, Trump DL, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB.

Int J Cancer. 2016 May 1;138(9):2118-26. doi: 10.1002/ijc.29954. Epub 2015 Dec 28.

12.

Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.

Mazzilli SA, Hershberger PA, Reid ME, Bogner PN, Atwood K, Trump DL, Johnson CS.

Cancer Prev Res (Phila). 2015 Oct;8(10):895-904. doi: 10.1158/1940-6207.CAPR-14-0403. Epub 2015 Aug 14.

13.

MAC: identifying and correcting annotation for multi-nucleotide variations.

Wei L, Liu LT, Conroy JR, Hu Q, Conroy JM, Morrison CD, Johnson CS, Wang J, Liu S.

BMC Genomics. 2015 Aug 1;16:569. doi: 10.1186/s12864-015-1779-7.

14.

Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.

Bothwell KD, Shaurova T, Merzianu M, Suresh A, Kuriakose MA, Johnson CS, Hershberger PA, Seshadri M.

Cancer Prev Res (Phila). 2015 Sep;8(9):765-76. doi: 10.1158/1940-6207.CAPR-14-0454. Epub 2015 Jun 22.

15.

Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.

Steck SE, Arab L, Zhang H, Bensen JT, Fontham ET, Johnson CS, Mohler JL, Smith GJ, Su JL, Trump DL, Woloszynska-Read A.

PLoS One. 2015 Apr 28;10(4):e0125151. doi: 10.1371/journal.pone.0125151. eCollection 2015.

16.

SCNVSim: somatic copy number variation and structure variation simulator.

Qin M, Liu B, Conroy JM, Morrison CD, Hu Q, Cheng Y, Murakami M, Odunsi AO, Johnson CS, Wei L, Liu S, Wang J.

BMC Bioinformatics. 2015 Feb 28;16:66. doi: 10.1186/s12859-015-0502-7.

17.

Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectives.

Liu B, Conroy JM, Morrison CD, Odunsi AO, Qin M, Wei L, Trump DL, Johnson CS, Liu S, Wang J.

Oncotarget. 2015 Mar 20;6(8):5477-89. Review.

18.

1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells.

Ma Y, Hu Q, Luo W, Pratt RN, Glenn ST, Liu S, Trump DL, Johnson CS.

J Steroid Biochem Mol Biol. 2015 Apr;148:166-71. doi: 10.1016/j.jsbmb.2014.09.020. Epub 2014 Sep 26. Review.

19.

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.

Shen J, Hu Q, Schrauder M, Yan L, Wang D, Medico L, Guo Y, Yao S, Zhu Q, Liu B, Qin M, Beckmann MW, Fasching PA, Strick R, Johnson CS, Ambrosone CB, Zhao H, Liu S.

Oncotarget. 2014 Jul 30;5(14):5284-94.

20.

Vitamin D and miRNAs in cancer.

Ma Y, Trump DL, Johnson CS.

Curr Gene Ther. 2014;14(4):269-75. Review.

PMID:
25039615

Supplemental Content

Loading ...
Support Center